!!Frank Grosveld - Curriculum vitae
\\
__Education__
\\
*1965-1968:	Chemistry, University of Amsterdam
*1968-1972:	Biochemistry, University of Amsterdam (Dutch equivalent M.Sc.)
*1972-1976:	Biochemistry, McGill University, Montreal, Canada.
\\
__Professional experience__
\\
*1977		EMBO Fellow with Professor C. Weissmann, University of Zurich.
*1978		Research Associate with Professor C. Weissmann.
*1979		Research Associate with Dr. R. A. Flavell, University of Amsterdam.
*1980	        Royal Society Fellowship with Dr. R. A. Flavell at the National Institute for Medical Research, Mill                Hill, London.
*1981		MRC short-term appointment. National Institute for Medical Research, Mill Hill, London.
*1982		Head of Division of Gene Structure and Expression, National Institute for Medical Research, Mill Hill,                London.
*1993		Appointment to Full Professor at the Dept. of Cell Biology at the Medical Faculty of the Erasmus         University, Rotterdam, The Netherlands.
\\
__Honours/prizes__
\\
*1986		Elected to membership of EMBO
*1991		Jeantet Prize Medicine
*1991		Elected Fellow of the Royal Society
*1992		Howard Hughes International Research Scholar Award
*1994		Elected member of the Dutch Royal Academy of Sciences
*1994		Elected member of the New York Academy of Sciences
*1995		Spinoza prize NWO, The Netherlands
*2008		KNAW Professorship (Dutch Royal Academy of Sciences)
\\
__Editorial boards __
\\
*1996-present		Editorial board member of Genes to Cells
*1997			Senior editor Genes & Function
*1998-present		Editorial board member of Molecular Cell
*1999-present		Editorial board member of Gene Therapy and Regulation
*1999-2005		Editorial board member of The European Haematology Journal
*2000-present		Editorial board member of EMBO
*2001-present		Editorial board member of EMBO Reports
*2008-present		Epigenetics and Chromatin, co-editor-in-chief
\\
__Commercial biotech activities __
\\
*1993	Cofounder of Therexsys, now Cobra Therapeutics (UK)
*1998	Cofounder of 3Ophus (Rotterdam)
*1999	Cofounder of Minos (Greece and Rotterdam)
*2003	Setting up Harbour Antibodies (Rotterdam)
*2004	Setting up Minos Protein Products (Rotterdam)
*2004	Setting up Minos Genomics (Rotterdam)
\\
__10 key publications__
\\ 
Grosveld, F., Blom van Assendelft, G., Greaves, D. and Kollias, G.
Position-independent high level expression of the human ß-globin gene in transgenic mice. 
Cell, 51, 975-985, 1987.

Greaves, D. R., Fraser, P., Vidal, M. A., Hedges, M. J., Ropers, D., Luzzatto, L. and Grosveld, F. 
A transgenic mouse model of sickle cell disorder. 
Nature, 343, 183-185, 1990.

Hanscombe, O., Whyatt, D., Fraser, P., Yannoutsos, N., Greaves, D., Dillon, N. & Grosveld, F. 
Importance of globin gene order for correct developmental expression. 
Genes & Devel., 5, 1387-1394, 1991

Wijgerde, M.G.J.M., Grosveld, F.G. and Fraser, P.J. 
Transcription complex stability and chromatin dynamics in vivo. 
Nature, vol. 377: 209-213, 1995.

Whyatt, D., Lindeboom, F., Karis, A., Milot, E., Hendriks, R., de Bruijn, M., Langeveld, A., Gribnau, J., Grosveld, F. and Philipsen, S. 
An intrinsic but cell nonautonomous defect in GATA-1 overexpressing mouse  erythroid cells.  
Nature, 406:519-524, 2000.

Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F. and De Laat, W.
Looping and interaction between hypersensitive sites in the active ß-globin locus. 
Molecular Cell, 10:1-20, 2002.

Patrinos, G., de Krom, M., de Boer, E., Langeveld, A., Imam, A., Strouboulis, J., de Laat W. and Grosveld, F. Multiple interactions between regulatory regions are required to stabilise an Active Chromatin Hub. 
Genes & Dev. 18(12):1495-509, 2004.

Rodriguez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, Heck AJ, Vyas P, de Boer E, Grosveld F, Strouboulis J.
GATA-1 forms distinct activating and repressive complexes in erythroid cells.
EMBO J. 2005;24:2354-66.

Natalia Meier, Sanja Krpic, Patrick Rodriguez, John Strouboulis, Maria
Monti, Jeroen Krijgsveld, Martin Gering, Roger Patient , Arnd Hostert,
Frank Grosveld. Novel binding partners of Ldb1 are required for
haematopoietic development, Development. 2006;133:4913-23.

Monkhorst K, Jonkers I, Rentmeester E, Grosveld F, Gribnau J. X
inactivation counting and choice is a stochastic process: evidence for
involvement of an X-linked activator.
Cell. 2008;132:410-21.